Nardil Related Published Studies
Well-designed clinical trials related to Nardil (Phenelzine)
Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial. [2007.08]
Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients. [2004.11]
Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep. [2003.03]
Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. [1999.05]
Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. [1998.12]
Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. [1997.09]
Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. [1997.01]
Fluoxetine versus phenelzine in atypical depression. [1996.11.15]
Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. [1996.04]
A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives. [1994.01]
Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. [1993.12]
Chronic depression: response to placebo, imipramine, and phenelzine. [1993.12]
Efficacy of phenelzine and haloperidol in borderline personality disorder. [1993.05]
A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. [1993.01]
Haloperidol vs. phenelzine in continuation therapy of borderline disorder. [1993]
Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. [1992.11]
Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. [1992.04]
Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. [1991.06]
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design. [1991.04]
Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study. [1991]
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. [1990.10]
Phenelzine and atenolol in social phobia. [1990]
Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo. [1989.12]
Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression. [1989.09]
A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. [1989.09]
A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. [1988.10]
The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients. [1988.08]
Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol. [1988.07]
Well-designed clinical trials possibly related to Nardil (Phenelzine)
Validity of sudden gains in acute phase treatment of depression. [2005.02]
Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. [1996]
Self selection and sample selection in a treatment study of social phobia. [1995.03]
Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant. [1994.08]
Duration of antidepressant trials: clinical and research implications. [1994.02]
Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. [1993.09]
[Impact of personality factors in depression] [1993.08]
Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies. [1993]
Predictive value of symptoms of atypical depression for differential drug treatment outcome. [1992.06]
Can mildly depressed outpatients with atypical depression benefit from antidepressants? [1992.05]
Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. [1991.10]
Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants. [1991.09]
Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans. [1991.05]
The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients. [1989.09]
10-Hydroxynortriptyline and treatment effects in elderly depressed patients. [1989.03]
Other research related to Nardil (Phenelzine)
The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. [2007.11]
Acute myocarditis after massive phenelzine overdose. [2007.11]
Other possibly related research studies
Antidepressant-Associated Mood Elevations in Bipolar II Disorder Compared With Bipolar I Disorder and Major Depressive Disorder: A Systematic Review and Meta-Analysis. [2008.07.15]
Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies. [2007.08]
Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression. [2007.09]
Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports. [2007.08]
Treating DSM-IV depression with atypical features. [2007.04]
Translating the evidence on atypical depression into clinical practice. [2007]
Treating depression with atypical features. [2007]
Antidepressant therapy in tinnitus. [2007.04]
|
